[Aminoglycosides therapy in patients with bacteraemia]
Related Experiment Video
Updated: Jul 7, 2026

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
Published on: July 2, 2013
Morten Freundlich1, Reimar W Thomsen, Lars Pedersen
1Arhus Universitetshospital, Aalborg Sygehus, Aalborg.
Abstract:
Metaanalyses have questioned the use of aminoglycosides (AG). We studied the association between AG therapy, mortality and impairment of renal function among patients with bacteraemia who were given appropriate empirical antibiotic therapy with or without AG. Thirty-day mortality was similar in the two groups. AG was associated with decreased mortality in patients with a urinary tract or abdominal focus and with increased mortality in patients with pneumonia. AG therapy modestly increased the risk of rise in serum creatinine. AG therapy appears equivalent to other covering antibiotic regimens.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Estimation of k and VD of Aminoglycosides
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations